QureBio Ltd. to Showcase its Q-1802 Clinical Advances at 2022 ...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SHANGHAI, May 31, 2022 /PRNewswire-AsiaNet/ -- QureBio Ltd., a clinical-stage biopharmaceutical company focusing on bi-specific antibodies and other engineered bio-therapeutics for the treatment of cancer, inflammation, and other serious disorders, today announced that its Q-1802 clinical prog...
Authors: LATEST ASIANET NEWS RELEASES